MedPath
HSA Approval

HIDONAC SOLUTION FOR INFUSION 5 g/25 ml

SIN12132P

HIDONAC SOLUTION FOR INFUSION 5 g/25 ml

HIDONAC SOLUTION FOR INFUSION 5 g/25 ml

November 30, 2002

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Licence HolderUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

V03AB23

acetylcysteine

Manufacturer Information

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Alfasigma S.p.A.

Active Ingredients

N-ACETYLCYSTEINE

5 g/25 ml

Acetylcysteine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HIDONAC SOLUTION FOR INFUSION 5 g/25 ml - HSA Approval | MedPath